Hydromorphone Hydrochloride 63323-0853-25
- Manufacturer
- Fresenius Kabi Usa, Llc
- Dosage Form
- Injection, Solution
- Route
- Intramuscular, Intravenous, And Subcutaneous
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CII
- Marketing Start
- December 15, 2017
- Listing Expires
- December 31, 2026
- Application
- NDA019034
Active Ingredients
| Ingredient | Strength |
|---|---|
| Hydromorphone Hydrochloride | 2 mg/mL |
Drug Class
Full Opioid Agonists [MoA]Opioid Agonist [EPC]
Selected Package
63323-0853-25Selected25 VIAL, SINGLE-DOSE in 1 CARTON (63323-853-25) / 1 mL in 1 VIAL, SINGLE-DOSE (63323-853-03)